The European Commission fined Teva Pharmaceutical €462.6 million for misusing the patent system to delay competition for its multiple sclerosis drug Copaxone, showcasing commitment to enforcement in the pharmaceutical sector.
Former USPTO Director Andrei Iancu endorsed Donald Trump, criticizing Vice President Harris’s approach to AI and biotech while advocating for reforms to enhance U.S. competitiveness.
The report noted a significant surge in patent filings, highlighting that tech giants and the semiconductor industry are leading the growth in patent activities.
Iancu's commentary emphasizes the necessity for policy changes that support innovation and uplift small businesses, reflecting broader concerns about the competitiveness of the U.S. economy.
Collection
[
|
...
]